TRANSLATIONAL AND CLINICAL MEDICINE - Georgian Medical Journal

 Abstract
Background:  Psoriasis is the psycho-dermatological disease of chronic and inflammatory nature. Psychological factors are causing and / or aggravate during a psoriasis. Disease exacerbates the presence of nervous stress and worsens the quality of life of patients. Patients suffering from psoriasis try to deal with the problem using different coping strategies.  It is important to define patient's coping strategy towards Dermatology Life Quality Index.
Aim: Ability to use of patients coping strategies for determining of Dermatology life Quality Index in psoriasis patients.
Methods: Ten patients with psoriasis were enrolled in the study.  Dermatology Life Quality Index score of psoriasis was assessed by the DLQI Questionnaire and through the formula we have adopted.
Results: The results of the study indicated minor difference between the indicators, which confirms the high susceptibility of formulas.
Conclusions:  Psoriasis is a distressing disorder that significantly impairs quality of life. There is a close link between quality of life and coping strategies. We have shown that the values we have obtained from the Dermatology life Quality Index  questionnaire and using the new formula with multiple variables, do not nearly differ from each other and the formulas are suitable for use in daily clinical practice.
Keywords: Psoriasis; Coping strategies; Dermatology Life Quality Index; Formulas.

References:

Rosa P, Debrah P, Simmons S, Christopher E. Global epidemioligy of psoriasis: A sistematic review of incidence and prevalence. J Inv Dermatol. 2012; 25: 65-71.

Rachakonda TD, Schupp SW, Armstrong AW. Psoriasis prevalence among adults in the Unitedstates. J Am Acad Dermatol. 2014; 70: 512-516.

Schmid Ott G, Schallmayer S, Galliness IT. Quality Of Life in patients with psoriasis and psoriatic arthritis with a special focus on stigmatization experience. Clin Dermatol. 2007; 25 (6):547-554.

Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on Qualityof Life in psoriasis patients.Br J Dermatol. 2002; 147 (4): 736-742.

Hrehorov E, Salomon J, Matusiak L, Reich A, Czepietowski CZ. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012; 92: 67-72.

Lombardo G, Farina B, Pasquini B. Psychological distress and coping strategies in patients attending dermatology outpatient clinic. JEADV. 2012; 26:746-754.

Sarcar R, Chugh S, Bansal S.General measures and quality of life issue in psoriasis. Ind. J. Dermatol. 2016; 23:481-488.

Meeuwis KA, de Hullu JA, van de Nieuwenhof HP at al. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol.2011; 164 (6):1246-1255..

Lakuta P, Marcinkiewicz K, Bergler- Czop B, Brzezinska – Wcislo L, Slomian A. Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. Postepy Dermatol alergol. 2018; 35 (1):60-66.

Parrish L. Psoriasis: symptoms, treatments and its impact on quality of life. Br. J. Community Nurs. 2012; 17(11):524-528.

Polijan TZ, Kovacevic D, Vlastelica M, Dadic-Hero E, Sarilar M .Quality of life of persons suffering from Schizophrenia, psoriasis and physical disabilities. Psychiatr. Danub. 2017; 29(1): 60-65.

Mermid D, Baursault L, Milpied B, Taieb A, Ezzedine K, Seneschal J . DLQI as a major criterion for introduction of systemic agents in patients with mild psoriasis. JEADV. 2016; 30 (11):1961-1964.

Konkan R, Erkus GH, Guclu O at al. Coping Strategies in Patients Who Had Suicide Attempts. Noro Psikiyatr Ars. 2014; 51 (1); 46-51.

Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 1989; 56: 267-83.

Liluashvili S, Kituashvili T. Dermatology Life Quality Index and disease coping strategies in psoriasis patients. Adv Dermatol Allergol. 2018; 4: 1-6.